Document is current
Any future updates will be listed below
-
Authors
Samarai, Daniel
Isma, Nazim
Lindstedt, Sandra
Hlebowicz, Joanna https://orcid.org/0000-0002-9515-7240
-
Funding
Funding for this research was provided by:
Anna-Lisa and Sven Eric Lundgren Foundation for Medical Research.
Skånes universitetssjukhus (92216)
- License Information
-
More Information
Article History
Received: 7 July 2022
Accepted: 28 December 2022
First Online: 10 January 2023
Declarations
:
: This study ranged from 01/01/2006 to 23/02/2017 and involved all patients on oral anticoagulation treatment that were registered SWEDCON, the Swedish National Quality Registry for Congenital Heart Disease, in the South Region of Sweden (Region Skåne). All patients included in SWEDCON are in accordance with a waiver regarding written informed consent supported by the proper authorities. Written or verbal information are the only requirements on a national level. The study was approved by the Regional Ethics Review Board in Lund, Sweden (Dnr 2017/260). The investigation conforms to the principles outlined in the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
